vs
ABVC BIOPHARMA, INC.（ABVC）与reAlpha Tech Corp.（AIRE）财务数据对比。点击上方公司名可切换其他公司
reAlpha Tech Corp.的季度营收约是ABVC BIOPHARMA, INC.的1.1倍（$895.3K vs $796.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -541.6%，领先285.0%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs 70.1%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs 562.1%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
reAlpha Tech Corp是一家房地产科技企业，依托人工智能技术识别、收购并运营美国境内高收益的短租住宅物业，同时提供技术驱动的物业管理方案，优化住客体验，为个人及机构房产投资者提升资产收益。
ABVC vs AIRE — 直观对比
营收规模更大
AIRE
是对方的1.1倍
$796.0K
营收增速更快
ABVC
高出34.4%
70.1%
净利率更高
ABVC
高出285.0%
-541.6%
两年增速更快
ABVC
近两年复合增速
562.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $895.3K |
| 净利润 | $-2.0M | $-4.8M |
| 毛利率 | 100.0% | 62.7% |
| 营业利润率 | -246.8% | -507.8% |
| 净利率 | -256.6% | -541.6% |
| 营收同比 | 104.5% | 70.1% |
| 净利润同比 | -417.4% | 76.9% |
| 每股收益（稀释后） | $-0.09 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCAIRE
| Q4 25 | — | $895.3K | ||
| Q3 25 | $796.0K | $1.4M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $925.6K | ||
| Q4 24 | $2.0K | $526.4K | ||
| Q3 24 | $389.3K | $339.2K | ||
| Q2 24 | $117.1K | $62.4K | ||
| Q1 24 | $1.2K | $20.4K |
净利润ABVCAIRE
| Q4 25 | — | $-4.8M | ||
| Q3 25 | $-2.0M | $-5.8M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $-2.8M | ||
| Q4 24 | — | $-21.0M | ||
| Q3 24 | $-394.8K | $-2.1M | ||
| Q2 24 | $-942.3K | $-1.5M | ||
| Q1 24 | $-2.8M | $-1.4M |
毛利率ABVCAIRE
| Q4 25 | — | 62.7% | ||
| Q3 25 | 100.0% | 51.9% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 56.0% | ||
| Q4 24 | 100.0% | 71.1% | ||
| Q3 24 | 99.9% | 66.6% | ||
| Q2 24 | 99.8% | 70.7% | ||
| Q1 24 | 77.0% | 10.7% |
营业利润率ABVCAIRE
| Q4 25 | — | -507.8% | ||
| Q3 25 | -246.8% | -342.4% | ||
| Q2 25 | — | -326.5% | ||
| Q1 25 | — | -261.7% | ||
| Q4 24 | — | -524.6% | ||
| Q3 24 | -77.7% | -479.1% | ||
| Q2 24 | -734.2% | -1939.6% | ||
| Q1 24 | -235539.8% | -6397.0% |
净利率ABVCAIRE
| Q4 25 | — | -541.6% | ||
| Q3 25 | -256.6% | -400.1% | ||
| Q2 25 | — | -328.3% | ||
| Q1 25 | — | -307.9% | ||
| Q4 24 | — | -3994.4% | ||
| Q3 24 | -101.4% | -618.6% | ||
| Q2 24 | -804.4% | -2370.9% | ||
| Q1 24 | -235203.2% | -6946.9% |
每股收益（稀释后）ABVCAIRE
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.09 | $-0.07 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.06 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | $-0.03 | $-0.05 | ||
| Q2 24 | $-0.08 | $-0.03 | ||
| Q1 24 | $-0.29 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $7.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $11.5M |
| 总资产 | $21.2M | $21.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCAIRE
| Q4 25 | — | $7.8M | ||
| Q3 25 | $257.2K | — | ||
| Q2 25 | — | $587.3K | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $313.1K | $3.1M | ||
| Q3 24 | $208.2K | $7.1M | ||
| Q2 24 | $200.0K | $3.7M | ||
| Q1 24 | $106.4K | $4.8M |
总债务ABVCAIRE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $152.9K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $241.1K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABVCAIRE
| Q4 25 | — | $11.5M | ||
| Q3 25 | $12.1M | $10.9M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $-972.3K | ||
| Q4 24 | $1.2M | $1.6M | ||
| Q3 24 | $1.6M | $22.5M | ||
| Q2 24 | $1.8M | $22.2M | ||
| Q1 24 | $1.7M | $23.3M |
总资产ABVCAIRE
| Q4 25 | — | $21.7M | ||
| Q3 25 | $21.2M | $19.7M | ||
| Q2 25 | — | $15.5M | ||
| Q1 25 | — | $18.5M | ||
| Q4 24 | $7.5M | $12.0M | ||
| Q3 24 | $7.8M | $34.2M | ||
| Q2 24 | $8.0M | $24.6M | ||
| Q1 24 | $8.0M | $25.4M |
负债/权益比ABVCAIRE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-11.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-11.3M |
| 自由现金流率自由现金流/营收 | — | -1262.7% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-20.2M |
8季度趋势，按日历期对齐
经营现金流ABVCAIRE
| Q4 25 | — | $-11.3M | ||
| Q3 25 | $-964.7K | $-4.2M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-2.3M | ||
| Q4 24 | $-1.8M | $-6.0M | ||
| Q3 24 | $60.2K | $-1.3M | ||
| Q2 24 | $-211.4K | $-1.0M | ||
| Q1 24 | $-955.8K | $-1.5M |
自由现金流ABVCAIRE
| Q4 25 | — | $-11.3M | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-2.3M | ||
| Q4 24 | — | $-6.1M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ABVCAIRE
| Q4 25 | — | -1262.7% | ||
| Q3 25 | — | -294.1% | ||
| Q2 25 | — | -187.5% | ||
| Q1 25 | — | -246.4% | ||
| Q4 24 | — | -1150.2% | ||
| Q3 24 | — | -372.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ABVCAIRE
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
